NYSE · Medical - Devices

Zimmer Biomet Holdings, Inc. (ZBH) Stock

$96.55 -0.66% NYSE: ZBH Healthcare

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products.

Valuation

MetricValue
Price$96.55
Market Cap$18.68B
P/E Ratio23.98
P/B Ratio1.30
P/S Ratio1.99
EPS (TTM)$3.55
52-Week High$108.29
52-Week Low$79.12
Dividend Yield1.11%

Financials & Margins

MetricValue
ROE5.55%
ROA3.05%
ROCE10.72%
Gross Margin16.56%
Operating Margin16.55%
Net Margin9.05%
Debt/Equity0.51
Current Ratio1.98

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.8B$6.9B$7.4B$7.7B$8.2B
Operating Profit$860.0M$696.0M$1.3B$1.3B$1.4B
Net Profit$402.0M$231.0M$1.0B$904.0M$705.0M
EPS$1.91$1.10$4.88$4.43$3.55
Op Margin12.6%10.0%17.3%16.7%16.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.5B$21.1B$21.5B$21.4B$23.1B
Total Liabilities$10.8B$9.0B$9.0B$8.9B$10.4B
Cash$378.0M$376.0M$416.0M$526.0M$592.0M
Borrowings$7.1B$5.7B$5.8B$6.2B$7.5B

Latest News

Earnings Preview: What To Expect From Zimmer Biomet’s Report Barchart · Jul 22, 2026 ISRG Stock: The Math Hidden In Its Price Trefis · Jul 21, 2026 The Robot Maker's Paradox Trefis · Jul 20, 2026 What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth? Trefis · Jul 20, 2026 3 Unpopular Stocks with Warning Signs StockStory · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.5B$1.3B$1.6B$1.5B$1.7B
Investing Cash Flow$-656.0M$-747.0M$-1.2B$-1.2B$-2.2B
Financing Cash Flow$-173.0M$418.0M$-617.0M$-825.0M$-530.0M
Net Cash Flow$-324.0M$-103.0M$40.0M$110.0M$66.0M
Free Cash Flow$1.3B$1.1B$1.2B$1.1B$1.5B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA9.53
FCF Yield10.95%
Quick Ratio1.61
Interest Coverage4.65
Return 1Y-2.95%
Return 3Y-35.71%
Return 5Y-39.72%

Ownership

Insiders Held0.15%
Institutions Held106.31%
Institutions Float Held106.47%
Institutional HolderSharesReport Date
Dodge & Cox Inc.23,542,7002026-03-31
Blackrock Inc.15,340,8062026-03-31
Harris Associates L.P.12,959,9392026-03-31
Vanguard Capital Management LLC12,793,4122026-03-31
Capital International Investors9,119,2222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet Holdings, Inc. is led by CEO Ivan Tornos, employs 17,000 people, headquartered in Warsaw, US, publicly traded since 2001.

Zimmer Biomet Holdings, Inc. (ZBH) stock trades at $96.55 with a market capitalization of $18.68B. The stock is valued at a price-to-earnings (P/E) ratio of 23.98, price-to-book of 1.30, price-to-sales of 1.99. Over the past 52 weeks the stock has ranged between $79.12 and $108.29, and currently trades 10.8% below its 52-week high. It pays a dividend yielding 1.11%.

On profitability, Zimmer Biomet Holdings, Inc. generates a return on equity (ROE) of 5.55%, return on capital employed of 10.72%, an operating margin of 16.55%, a net profit margin of 9.05%.

In its most recent fiscal year, Zimmer Biomet Holdings, Inc. reported annual revenue of $8.2B, net profit of $705.0M, revenue has compounded at 6.1% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 0.51, a current ratio of 1.98, total assets of $23.1B, $592.0M in cash and equivalents.

ZBH has an average daily trading volume of 2,430,000 shares, a beta of 0.47 (less volatile than the overall market).

Official website: www.zimmerbiomet.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides